9QEK
Structure of Human ROS1 Kinase Domain Harboring the G2032R Solvent-front Mutation in Complex with Zidesamtinib (NVL-520)
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE ID23-1 |
| Synchrotron site | ESRF |
| Beamline | ID23-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-01-19 |
| Detector | DECTRIS EIGER2 X CdTe 16M |
| Wavelength(s) | 0.885603 |
| Spacegroup name | P 64 |
| Unit cell lengths | 106.020, 106.020, 50.510 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 34.703 - 2.205 |
| Rwork | 0.201 |
| R-free | 0.27220 |
| Structure solution method | FOURIER SYNTHESIS |
| RMSD bond length | 0.003 |
| RMSD bond angle | 0.981 |
| Data reduction software | XDS (20220820) |
| Data scaling software | Aimless (0.7.13) |
| Phasing software | PHASER (5.8.0419) |
| Refinement software | REFMAC (5.8.0430) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 34.703 | 2.427 |
| High resolution limit [Å] | 2.205 | 2.205 |
| Rmerge | 0.086 | 1.373 |
| Rmeas | 0.093 | 1.495 |
| Rpim | 0.034 | 0.585 |
| Number of reflections | 12138 | 1214 |
| <I/σ(I)> | 11.2 | 1.5 |
| Completeness [%] | 73.4 | 29.7 |
| Redundancy | 7.6 | 6.4 |
| CC(1/2) | 0.998 | 0.671 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 4.83 | 285 | 0.6 M Potassium Thiocyanate, 0.1 M Citric Acid/Tri-sodium Citrate pH 4.83, 22% w/v PEG 3350 |






